ACTIVE

BIOMEDICAL DIAGNOSTICS

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

339,9 k €

-10.1% YoY

Gross margin

1,3 M €

-4.9% YoY

Equity

2,5 M €

+16.0% YoY

Workforce

7,4 ETP

+10.4% YoY

What does BIOMEDICAL DIAGNOSTICS do?

BIOMEDICAL DIAGNOSTICS is a Public limited company incorporated in 2003. Its registered office is in Antwerpen. It employs on average 7,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0479.414.976

Incorporation

28/01/2003

Legal form

Public limited company

Registered office

Noorderlaan 139
2030 Antwerpen · FlandreSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

7,4 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2009		2008		2007		2006
Income statement
Gross margin	1,3 M €	-4.9%	1,4 M €	-5.2%	1,4 M €	-6.2%	1,5 M €	+16.4%	1,3 M €	+9.3%	1,2 M €	-12.5%	1,4 M €	-10.1%	1,5 M €	+44.1%	1,1 M €	-3.2%	1,1 M €	+36.6%	808,9 k €	+16.6%	694 k €	-11.7%	786,1 k €	-10.8%	881,4 k €	-53.1%	1,9 M €	-8.9%	2,1 M €	-0.9%	2,1 M €	+25.6%	1,7 M €	+19.2%	1,4 M €
EBITDA	346,8 k €	-29.1%	489,4 k €	-34.6%	748,3 k €	-21.3%	950,2 k €	+45.0%	655,2 k €	+9.8%	596,6 k €	-20.8%	752,9 k €	-15.6%	892,5 k €	+107%	431,6 k €	-17.7%	524,1 k €	+76.7%	296,6 k €	+121%	134,1 k €	+153%	52,9 k €	-83.9%	329,6 k €	-64.9%	938,9 k €	-28.0%	1,3 M €	+1.7%	1,3 M €	+17.1%	1,1 M €	+22.3%	895,2 k €
Operating result	401,5 k €	-11.4%	453,2 k €	-37.8%	728,4 k €	-20.9%	920,9 k €	+45.0%	635,3 k €	+12.1%	566,7 k €	-19.8%	706,4 k €	-16.8%	849,1 k €	+123%	380,4 k €	-21.5%	484,4 k €	+111%	229,5 k €	+727%	27,8 k €	+156%	-49,7 k €	-121%	232,7 k €	-73.1%	864,4 k €	-30.6%	1,2 M €	+2.1%	1,2 M €	+17.7%	1 M €	+26.5%	818,8 k €
Net result	339,9 k €	-10.1%	378,1 k €	-37.3%	603 k €	+2.2%	590,2 k €	+20.4%	490,1 k €	-1.9%	499,4 k €	-14.9%	586,7 k €	-24.9%	781,3 k €	+165%	295 k €	-15.9%	350,6 k €	+102%	174 k €	+348%	38,8 k €	+30.6%	29,7 k €	-86.1%	213,2 k €	-64.4%	598,8 k €	-37.3%	954,8 k €	+17.9%	809,7 k €	+19.1%	680 k €	+29.0%	527,3 k €
Balance sheet
Equity	2,5 M €	+16.0%	2,1 M €	+21.6%	1,8 M €	+52.5%	1,1 M €	+106%	558,3 k €	+9.4%	510,4 k €	-44.0%	911 k €	+16.2%	784,2 k €	+20.1%	652,9 k €	+17.0%	558 k €	+37.0%	407,4 k €	-23.6%	533,4 k €	+7.9%	494,6 k €	+6.4%	464,9 k €	+84.7%	251,7 k €	-88.8%	2,3 M €	+32.7%	1,7 M €	+31.8%	1,3 M €	+59.4%	808,3 k €
Total assets	3,5 M €	+16.9%	3 M €	+16.0%	2,6 M €	+53.6%	1,7 M €	+1.2%	1,7 M €	-9.5%	1,8 M €	+0.0%	1,8 M €	-2.8%	1,9 M €	+43.7%	1,3 M €	+12.5%	1,2 M €	+45.0%	810,1 k €	-6.0%	862 k €	-11.3%	971,9 k €	-12.1%	1,1 M €	-34.9%	1,7 M €	-40.1%	2,8 M €	+22.7%	2,3 M €	+36.8%	1,7 M €	+21.2%	1,4 M €
Cash	501,4 k €	-27.8%	694,7 k €	-43.0%	1,2 M €	+103%	599,4 k €	+13.3%	529 k €	-39.8%	878,4 k €	+8.2%	811,9 k €	-7.6%	878,6 k €	+118%	402,6 k €	-7.2%	434 k €	+67.3%	259,4 k €	+199%	86,6 k €	-58.3%	207,5 k €	+13.1%	183,4 k €	-80.2%	924,9 k €	-37.6%	1,5 M €	+180%	528,2 k €	+69.0%	312,5 k €	-31.0%	452,9 k €
Debts	1 M €	+26.1%	827,7 k €	+7.4%	770,7 k €	+60.4%	480,5 k €	-54.7%	1,1 M €	-17.3%	1,3 M €	+45.5%	880,5 k €	-17.0%	1,1 M €	+73.9%	610 k €	+8.6%	561,9 k €	+65.2%	340,2 k €	+39.5%	244 k €	-40.9%	412,6 k €	-20.5%	518,9 k €	-60.8%	1,3 M €	+205%	433,7 k €	+5.7%	410,3 k €	+9.8%	373,6 k €	-35.6%	580,1 k €
Other
Workforce	7,4 ETP	+10.4%	6,7 ETP	+15.5%	5,8 ETP	+9.4%	5,3 ETP	-7.0%	5,7 ETP	-3.4%	5,9 ETP	-4.8%	6,2 ETP	-11.4%	7,0 ETP	-1.4%	7,1 ETP	0.0%	7,1 ETP	+4.4%	6,8 ETP	+6.2%	6,4 ETP	-9.9%	7,1 ETP	+2.9%	6,9 ETP	-10.4%	7,7 ETP	-15.4%	9,1 ETP	-1.1%	9,2 ETP	+21.1%	7,6 ETP	+4.1%	7,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 16 ended

Active mandates

Olivier Bosc

Director · since 27 février 2025 · until 20 juin 2028

Active

Eurobio Scientific SA

Director · since 13 juin 2022 · until 20 juin 2028

Active

STEENS MANAGEMENT

Managing director · since 13 juin 2022 · until 20 juin 2028 · 0479.370.040

Represented by Fabienne Steens

Active

Ended mandates

Eurobio Scientific Benelux

Director · since 13 juin 2022 · until 20 juin 2028 · 0424.732.712

Ended

Eurobio Scientific Benelux

Director · since 13 juin 2022 · until 20 juin 2028 · 0424.732.712

Ended

EUROBIO SCIENTIFIC sa

Director · since 13 juin 2022 · until 20 juin 2028

Ended

STEENS MANAGEMENT

Managing director · since 13 juin 2022 · until 20 juin 2028 · 0479.370.040

Represented by Fabienne Steens

Ended

At this address

Other companies at this address

Company	CBE no.
ACCENTIS● Active	0454.201.411
Accentis Property International● Active	0478.583.152
Ahlers Logistics● Active	0437.084.869
AXE INVESTMENTS/ SEA LLOYD● Active	0419.822.730
Baker & Baker Benelux(BE) NV● Active	0508.615.342
BESALEC● Active	0441.260.423
Chemist EU● Active	0786.836.581
CML Construction Services● Active	0720.852.233
Contargo Road Logistics Belgium● Active	0439.291.125
DoxBe● Active	0462.574.489
ERMICO● Active	0459.693.589
Falco Lines Belgium● Active	0456.035.701
FORTITUDE● Active	0549.831.137
GAC Belgium● Active	0556.740.210
GAIA● Active	1036.958.308
GAME PLAN● Active	0798.308.020
H-K Shipping● Active	0790.708.861
HOUBEN-STRABAG BIOSTOON BERINGEN● Active	0685.447.233
HOUBEN-STRABAG THORPARKING● Active	0700.368.209
IEP INVEST● Liquidation	0448.367.256

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/06/2026	24/06/2025	19/06/2024	26/06/2023	30/06/2022	23/07/2021
General meeting	16/06/2026	17/06/2025	18/06/2024	20/06/2023	21/06/2022	15/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	16/06/2026	19/06/2026	Dutch	PDF
Abridged model	31/12/2024	17/06/2025	24/06/2025	Dutch	PDF
Abridged model	31/12/2023	18/06/2024	19/06/2024	Dutch	PDF
Abridged model	31/12/2022	20/06/2023	26/06/2023	Dutch	PDF
Abridged model	31/12/2021	21/06/2022	30/06/2022	Dutch	PDF
Abridged model	31/12/2020	15/06/2021	23/07/2021	Dutch	PDF
Abridged model	31/12/2019	16/06/2020	09/07/2020	Dutch	PDF
Abridged model	31/12/2018	18/06/2019	31/07/2019	Dutch	PDF
Abridged model	31/12/2017	19/06/2018	16/07/2018	Dutch	PDF
Abridged model	31/12/2016	20/06/2017	14/07/2017	Dutch	PDF
Abridged model	31/12/2015	21/06/2016	20/07/2016	Dutch	PDF
Abridged model	31/12/2014	16/06/2015	09/07/2015	Dutch	PDF
Abridged model	31/12/2013	17/06/2014	02/07/2014	Dutch	PDF
Abridged model	30/06/2012	28/12/2012	25/01/2013	Dutch	PDF
Abridged model	30/06/2011	20/12/2011	19/01/2012	Dutch	PDF
Abridged model	31/12/2009	15/06/2010	09/07/2010	Dutch	PDF
Abridged model	31/12/2008	28/06/2009	27/07/2009	Dutch	PDF
Abridged modelCorrection	31/12/2007	17/06/2008	23/07/2008	Dutch	PDF
Abridged model	31/12/2007	17/06/2008	08/07/2008	Dutch	PDF
Abridged model	31/12/2006	19/06/2007	12/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 16 ended

Active mandates

Olivier Bosc

Director · since 27 février 2025 · until 20 juin 2028

Active

Eurobio Scientific SA

Director · since 13 juin 2022 · until 20 juin 2028

Active

STEENS MANAGEMENT

Managing director · since 13 juin 2022 · until 20 juin 2028 · 0479.370.040

Represented by Fabienne Steens

Active

Ended mandates

Eurobio Scientific Benelux

Director · since 13 juin 2022 · until 20 juin 2028 · 0424.732.712

Ended

Eurobio Scientific Benelux

Director · since 13 juin 2022 · until 20 juin 2028 · 0424.732.712

Ended

EUROBIO SCIENTIFIC sa

Director · since 13 juin 2022 · until 20 juin 2028

Ended

STEENS MANAGEMENT

Managing director · since 13 juin 2022 · until 20 juin 2028 · 0479.370.040

Represented by Fabienne Steens

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates26/11/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/05/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/10/2024
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring03/07/2024
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates15/04/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/07/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/11/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/11/2020
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025339,9 k €↓
2024
Annual accounts 2024378,1 k €↓
2023
Annual accounts 2023603 k €↑
2022
Annual accounts 2022590,2 k €↑
2021
Annual accounts 2021490,1 k €↓
2020
Annual accounts 2020499,4 k €↓
2019
Annual accounts 2019586,7 k €↓
2018
Annual accounts 2018781,3 k €↑
2017
Annual accounts 2017295 k €↓
2016
Annual accounts 2016350,6 k €↑
2015
Annual accounts 2015174 k €↑
2014
Annual accounts 201438,8 k €↑
2013
Annual accounts 201329,7 k €↓
2012
Annual accounts 2012213,2 k €↓
2011
Annual accounts 2011598,8 k €↓
2009
Annual accounts 2009954,8 k €↑
2008
Annual accounts 2008809,7 k €↑
2007
Annual accounts 2007680 k €↑
2006
Annual accounts 2006527,3 k €
28/01/2003
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

BIOMEDICAL DIAGNOSTICS

Overview

What does BIOMEDICAL DIAGNOSTICS do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline